Latest Financial Results News

Vitrafy Life Sciences reports strong progress in cryopreservation technology development and US market expansion following a successful $35 million IPO. The company highlights improved biological sample preservation outcomes and strategic commercial milestones.

Vitrafy Life Sciences reported a dramatic increase in half-year losses to $25.7 million, yet successfully raised $35 million through an IPO to fuel its cryopreservation technology expansion.

News Corporation has announced a USD 0.10 per share dividend for its Class A non-voting common stock, reflecting steady returns for investors amid a complex media landscape.

REA Group Ltd has delivered a robust half-year performance, reporting a 20% increase in revenue to $872.9 million and a 26% rise in net profit after tax to $313.9 million, driven by strong growth in both Australian and Indian markets.

REA Group announces CEO Owen Wilson will retire in the second half of 2025, concluding a decade marked by strong growth and innovation. The board has commenced a search for his successor to ensure a seamless leadership transition.

AMCOR PLC has announced an ordinary dividend of USD 0.1275 per security for the quarter ending December 2024, payable on March 18, 2025. The dividend is unfranked and offers currency flexibility for investors.

Amcor delivered steady volume and earnings growth in Q2 FY25, reaffirming its full-year guidance while progressing its transformative merger with Berry Global.

Sandon Capital Investments Limited has announced a fully franked ordinary dividend of AUD 0.014 per share for the quarter ending December 2024, payable in March 2025. The company’s Dividend Reinvestment Plan remains active, offering shareholders flexibility in participation.

Ten Sixty Four Limited has revealed a staggering net loss of US$43 million for the year ended June 2024, alongside a sharp 94% revenue decline and a modified audit opinion, raising fresh questions about its financial stability.

ResMed Inc. reported robust financial results for the quarter ended December 31, 2024, with a 10% increase in net revenue and a 65% jump in net income, driven by strong demand across its Sleep and Breathing Health and Residential Care Software segments.

Althea Group Holdings reported a 20% increase in customer receipts to $9.01 million for Q2 FY25, while addressing governance lapses and reviewing its FY25 guidance. The company is advancing operational improvements and cost savings as it prepares for a pivotal Federal Court hearing.

Jervois Global Limited has entered a pivotal recapitalization agreement with Millstreet Capital Management, involving a US$145 million equity injection and a pre-packaged Chapter 11 bankruptcy process. The company aims to strengthen its balance sheet and continue operations uninterrupted while preparing for a strategic restart of its nickel-cobalt refinery in Brazil.